Category: Life Sciences

Introduction Bringing a new drug to market is a slow and laborious process. According to Tufts Centre for the Study of Drug Development, it takes on average between 7 to 10 years and costs more than $2.5 billion to bring a new drug to market. (1) More than half of this time and capital is […]

Good practice (GxP) guidelines were established by the Food and Drug Administration (FDA) and aim to ensure organizations working in life sciences develop, manufacture, and distribute products that are safe, meet quality guidelines, and are fit for use. GxP compliance has been a part of the life sciences industry for many years and heavily influences […]

Analysis of large-scale genomic data is the foundation for developing new treatments that make personalized medicine a reality. However, access to these multi-petabyte datasets brings challenges in terms of managing storage and compute infrastructure. The scale and flexibility of AWS resources are ideal for such projects. AWS has developed a Reference Architecture for compression and […]

The Dark Data Problem Up to 80% of your organization’s medical patient data is untapped, undervalued, or unused Imagine walking into a physician’s office for a checkup. As you describe some pain you’ve been having in your left knee, the doctor barely looks up from the screen as she clatters away on the keyboard, taking […]

Gaining insights and knowledge from real-world health data (RWD), i.e., data acquired outside the context of randomized clinical trials, has been an area of continued opportunity for pharma organizations. In this webinar, you will hear about Sanofi’s journey and experience in building an industrialized big data & analytics platform in the cloud that handles billions […]

With over 75 launches and announcements of new services and major features during re:Invent, it can be hard for any technologist to keep track of the most relevant information for Healthcare and Life Science (HCLS) workloads. Explore the below recap of information important for HCLS customers and links to the top re:Invent breakout sessions. Top […]

The below post was written by guest author Shannon Axelrod, Senior Software Engineer at the Chan Zuckerberg Initiative. At the Chan Zuckerberg Initiative (CZI), the science team’s goal is to support the science and technology that will make it possible to cure, prevent, or manage all diseases by the end of this century. In particular, the organization […]

Amazon Managed Blockchain is a fully managed service that makes it easy to create and manage scalable blockchain networks using popular open source frameworks, such as Hyperledger Fabric and Ethereum. General availability of Hyperledger Fabric was announced in April 2019, with support for Ethereum coming soon. For additional details about Managed Blockchain, see What Is Amazon […]

Today, AWS announced a new strategic collaboration with Novartis that will transform Novartis’ core supply chain, manufacturing, and delivery operations through the use of AWS services. For several years, many AWS partners and life science customers have been using AWS services to modernize various aspects of manufacturing and supply chain. This strategic collaboration with Novartis […]

Technology is changing how we practice medicine. Sensors and wearables are getting smaller and cheaper, and algorithms are becoming powerful enough to predict medical outcomes. Yet despite rapid advances, healthcare lags behind other industries in truly putting these technologies to use. A major barrier to entry is the cross-disciplinary approach required to create such tools, […]